CClinicalTrials.gg
RecruitingNCT07317388AUTON'HOMEUpdated Jan 5, 2026

Group Psychoeducation to Promote Independent Living in Individuals With Psychiatric Disorders

An observational study in Psychiatric Disorder, sponsored by Centre hospitalier de Ville-Evrard, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Centre hospitalier de Ville-Evrard, France · Observational

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
24
Ages
18 Years and older
Sex
All
01

Study summary

This study evaluates the effectiveness of group psychoeducation for users and carers to help people with severe psychiatric disorders achieve autonomy at home.

Read the detailed description

The study will assess the autonomy of users with severe psychiatric disorders in a home setting before and after participation in the psychoeducation group. The program includes 10 sessions focusing on various aspects of daily living and cognitive functions.

02

Conditions studied

  • Psychiatric Disorder

Keywords

  • psychoeducation
  • autonomy
  • mental health
  • group therapy
  • independent living
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's planned enrollment of 24 is below the median of 200 across 480 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Centre hospitalier de Ville-Evrard, France is the lead sponsor of 22 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants with severe psychiatric disorders, managed by the RPS 93 platform, and volunteers for a home autonomy project.

Inclusion criteria

  • Volunteer for a home autonomy project
  • Management of a mental health problem (mood disorder or psychotic disorder)
  • Consent for participation (non-opposition)
  • Taken care by the RPS 93 platform

Exclusion criteria

Exclusion Criteria:

  • Acute clinical state
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
24 participants (estimated)
Patient registry
No

Groups and cohorts

  • AUTON'HOME Group 1

    Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

  • AUTON'HOME Group 2

    Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

  • AUTON'HOME Group 3

    Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

  • AUTON'HOME Group 4

    Group of 6 patients with severe mental disorders (mood or psychotic disorders), residing in Seine-Saint-Denis, supported by the RPS platform. They participate in a 10-week psychoeducation program called 'AUTON'HOME', aimed at improving their autonomy at home. The program includes 10 thematic sessions on cognitive functions, daily living skills, hygiene, housing management and social participation. Evaluations are conducted before and 3 months after the program.

06

What researchers measure

Primary outcomes

  1. Life Habits Assessment Tool

    Assessing the autonomy of users with severe psychic pathologies in housing before and after participation in the psychoeducation group.

    Time frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

Secondary outcomes

  1. Center for Epidemiologic Studies Depression Scale

    Assesses emotional impressions and depressive symptoms in caregivers.

    Time frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

  2. Zarit Burden Interview Scale

    Quantifies caregiver burden.

    Time frame: Baseline, at the end of the 10-week AUTON'HOME psychoeducation program, and 3 months after program completion

  3. Family Expectations Questionnaire

    It aims to collect the expectations of family members regarding the autonomy and daily functioning of their loved one living with a severe mental disorder.

    Time frame: Baseline (prior to initiation of the AUTON'HOME psychoeducation program)

  4. Family Expectations Fulfillment Questionnaire

    It evaluates whether the expectations previously expressed by the family have been fulfilled, partially met, or unmet.

    Time frame: At the end of the 10-week AUTON'HOME psychoeducation program and 3 months after program completion

  5. Positive and Negative Syndrome Scale

    Measures severity of psychiatric symptoms.

    Time frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

  6. Clinical Global Impression

    Assesses global improvement compared to baseline.

    Time frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

  7. Montreal Cognitive Assessment

    Screens for mild to moderate cognitive impairments.

    Time frame: Baseline and 3 months after completion of the 10-week AUTON'HOME psychoeducation program

07

Study locations

1 of 1 sites recruiting
  • EPS VIlle Evrard - UNIRRE 93
    Neuilly-sur-Marne, France
    Recruiting
08

References and documents

Publications

  • Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Syst Rev. 2011 Jun 15;(6):CD002831. doi: 10.1002/14651858.CD002831.pub2. PubMed 21678337 ↗
  • Somerville, P., (1998). " Empowerment through Residence ", Housing Studies, Vol. 13, n° 2, pp. 233-258.
  • Richard, M.-J., Touroude, R., Loubier , D. (2018) Habitat et accompagnement. Santé mentale, 228, 42-47.
  • Pan AW, Fisher AG. The Assessment of Motor and Process Skills of persons with psychiatric disorders. Am J Occup Ther. 1994 Sep;48(9):775-80. doi: 10.5014/ajot.48.9.775. PubMed 7977620 ↗
  • Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV, Patterson TL. Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res. 2008 Mar;42(4):320-7. doi: 10.1016/j.jpsychires.2006.12.008. Epub 2007 Feb 15. PubMed 17303168 ↗
  • Leguay D, Cochet A, Matignon G, Hairy A, Fortassin O, Marion JM. [Social Autonomy Scale. First validation data]. Encephale. 1998 Mar-Apr;24(2):108-19. French. PubMed 9622789 ↗
  • Latalova K. Insight in bipolar disorder. Psychiatr Q. 2012 Sep;83(3):293-310. doi: 10.1007/s11126-011-9200-4. PubMed 22101737 ↗
  • Gaudelus, B., (2018). Quels outils pour évaluer la capacité à habiter, Santé mentale, 228,48-54.
  • Beaulieu A, Morin P, Provencher H, Dorvil H. [Work as a social determinant of health for mental health services consumers.]. Sante Ment Que. 2002;27(1):177-93. French. PubMed 18253624 ↗
  • Chambon, N., Picolet, É. & Sorba, M. (2020). L'intervention sociale à l'épreuve d'une préoccupation pour la santé mentale. Mobilisation du rétablissement et politique de logement d'abord. Revue française des affaires sociales, 97-116.
  • Barres, M., (2016) L'action de la psychiatrie pour l'accès et le maintien dans le logement des personnes vivant avec des troubles psychiques en Île-de-France. https://bibliotheques.ghu-paris.fr/doc_num.php?explnum_id=1299
  • Bond K, Anderson IM. Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials. Bipolar Disord. 2015 Jun;17(4):349-62. doi: 10.1111/bdi.12287. Epub 2015 Jan 16. PubMed 25594775 ↗
  • Baier M. Insight in schizophrenia: a review. Curr Psychiatry Rep. 2010 Aug;12(4):356-61. doi: 10.1007/s11920-010-0125-7. PubMed 20526897 ↗
  • Amado, C., Musset, T., & Gozlan, G., (2018). Le SAMSAH'Appart, espace d'évaluation et d'apprentissage. Santé mentale, 228, 69-70.
  • Alhadidi MM, Lim Abdullah K, Yoong TL, Al Hadid L, Danaee M. A systematic review of randomized controlled trials of psychoeducation interventions for patients diagnosed with schizophrenia. Int J Soc Psychiatry. 2020 Sep;66(6):542-552. doi: 10.1177/0020764020919475. Epub 2020 Jun 7. PubMed 32507073 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07317388
Lead sponsor
Centre hospitalier de Ville-Evrard, France
Responsible party
Raluca ROSETTI (Principal Investigator, Centre hospitalier de Ville-Evrard, France) — Principal investigator
First posted
Jan 5, 2026
Start date
May 1, 2025
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Jan 5, 2026

Study contacts

Youcef BENCHERIF, Clinical Project Manager
Contact
y.bencherif@epsve.fr
01.43.09.32.32
Raluca ROSETTI, Docrorat d'Etat en Médecine
principal investigator · EPS VILLE EVRARD

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion